A Double Blind, Dose Range, Placebo Controlled Study of the Effects of Rostafuroxin vs Placebo in Patients With Stable, Uncomplicated, Essential Hypertension.

Trial Profile

A Double Blind, Dose Range, Placebo Controlled Study of the Effects of Rostafuroxin vs Placebo in Patients With Stable, Uncomplicated, Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Sep 2014

At a glance

  • Drugs Rostafuroxin (Primary)
  • Indications Essential hypertension
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms OASIS-HT
  • Most Recent Events

    • 01 Jun 2007 Status change from recruiting to in progress
    • 11 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top